import {
  FACTS,
  GUARANTEES,
  INTL_DATE_MODIFIED,
  JETRO_MEA_REPORTS,
  OFFICES,
  INTL_HREFLANG_BY_PATH,
  PATHS,
  SPA_CHINESE_KSA,
  WAM_CHINESE_UAE,
} from './shared';
import type { IntlMoneyPage } from './types';

export const JAPAN_EN_INTL_PAGE: IntlMoneyPage = {
  id: 'japan',
  path: PATHS.japan,
  lang: 'en',
  htmlLang: 'en',
  nativeReviewRequired: false,
  title: 'Middle East Market Research for Japanese Companies',
  description:
    'Japan-to-GCC research for Japanese affiliates: Saudi and UAE physician surveys, Egypt entry, Arabic fieldwork. No Tokyo office. $10k–$60k. 48-hour proposal.',
  h1: 'Middle East Market Research for Japanese Companies',
  primaryKeyword: 'Middle East market research for Japanese companies',
  quickAnswer:
    'BioNixus runs Middle East market research for Japanese companies from a US headquarters in Sheridan, Wyoming, with Arabic–English fieldwork in Al Khobar, Dubai, Kuwait and Cairo. There is no Tokyo office. Japanese affiliates brief us for Saudi market entry, UAE physician surveys and Egypt studies. Custom work is $10,000–$60,000. Scope is guaranteed in writing.',
  breadcrumbLabel: 'Japan',
  dateModified: INTL_DATE_MODIFIED,
  coverImage: '/images/intl-outbound/japan-cover.jpg',
  heroImage: '/images/intl-outbound/japan-hero.jpg',
  coverAlt:
    'BioNixus navy and gold cover: Middle East market research for Japanese companies — Japan to GCC fieldwork',
  heroAlt:
    'Navy and gold BioNixus artwork for Japan to Middle East and Africa market research, with the repo logo and no stock photograph',
  areaServed: [
    { '@type': 'Country', name: 'Japan' },
    { '@type': 'Country', name: 'Saudi Arabia' },
    { '@type': 'Country', name: 'United Arab Emirates' },
    { '@type': 'Country', name: 'Egypt' },
    { '@type': 'Place', name: 'MENA' },
  ],
  proofPoints: [
    {
      title: 'Japan-to-MEA, not a Tokyo panel',
      description:
        'Japanese affiliates brief Sheridan or London. Fieldwork is in the Gulf and Cairo. BioNixus does not claim a Japan office.',
    },
    {
      title: 'Arabic instruments, Japanese readout',
      description:
        'Recruitment and moderation run in Arabic and English. The steering-committee pack can be written for a Tokyo or Osaka affiliate in English.',
    },
    {
      title: 'Intage and Macromill stay in Japan',
      description:
        'Keep domestic Japan suppliers for Japan-side work. Brief BioNixus when the sample is in Saudi Arabia, the UAE or Egypt.',
    },
  ],
  sections: [
    {
      id: 'who-this-is-for',
      heading: 'Who inside a Japanese company briefs Middle East research?',
      paragraphs: [
        `Middle East market research for Japanese companies is commissioned by the affiliate or the overseas business unit that owns Saudi Arabia, the UAE, Egypt or a wider GCC P&amp;L — not by the Japan domestic insights team that already has Intage or Macromill on contract. Typical buyers sit in Tokyo, Osaka or a US or European regional HQ and must take a Gulf question to a Japanese investment committee. This page is the English money page for that outbound brief. The Japanese-language twin is {link:/ja/market-research/japan|日本企業向け中東市場調査}. Start from the {link:/healthcare-market-research|healthcare market research} hub when the file is a physician or payer study.`,
        `Takeda, Astellas, Daiichi Sankyo, Eisai, Otsuka and their peers already run global insights stacks. Those stacks are strong in Japan and in the United States. They are thinner when the decision is an SFDA file, a NUPCO tender, a DHA formulary or an Egypt EDA price. The same gap shows up for Japanese corporates in automotive, energy, food and industrial equipment. Domestic Japan head terms such as “market research company Japan” belong to Intage and Macromill and are not the job of this page. See {link:/insights/top-market-research-companies-japan-2026|top market research companies in Japan} and {link:/healthcare-market-research/japan|healthcare market research in Japan} for the Japan-side directories.`,
        `BioNixus was founded in ${FACTS.founded}. Headquarters are in ${FACTS.hq}. Leadership offices are ${OFFICES.leadership}. Field offices are ${OFFICES.field}. The firm has served ${FACTS.clients} clients in ${FACTS.countries} countries and has run ${FACTS.studies2026} studies in 2026 year-to-date (${FACTS.studies2025} in 2025), with ${FACTS.physicians} physicians in the wider network. Custom pricing is ${FACTS.priceLow}–${FACTS.priceHigh}. BioNixus is ${OFFICES.saoPaulo}. There is no Tokyo, Osaka or Singapore premises to list, and this page will not invent one.`,
      ],
    },
    {
      id: 'saudi-entry',
      heading: 'Saudi market entry from Japan is a two-licence problem',
      paragraphs: [
        `Saudi market entry Japan briefs fail when the affiliate treats “the GCC” as one market and pastes a Japan discussion guide onto an English-only Gulf sample. Saudi Arabia is a separate licence, a separate tender stack and a separate Arabic instrument from the UAE. A Japanese team that has a Dubai free-zone entity still needs a MISA activity and, for medicines, an SFDA path. The research has to name the buyer, the city and the channel in the Kingdom before Tokyo remits capital.`,
        `JETRO already publishes a Middle East report shelf that Japanese affiliates use for desk context, including the annual survey of Japanese firms in the Middle East ({ext:${JETRO_MEA_REPORTS}|JETRO Middle East reports}). Those reports are useful and official. They are not a named physician sample, a hospital-account cut, or a consumer price file. BioNixus does not resell JETRO. It fields the primary interviews JETRO cannot sell.`,
        `Healthcare Saudi briefs sit next to {link:/healthcare-market-research/saudi-arabia|healthcare market research in Saudi Arabia}, {link:/blog/hematology-market-research-saudi-arabia|hematology market research in Saudi Arabia} and {link:/bionixus-industries/insights/market-entry-research-saudi-arabia|market entry research for Saudi Arabia}. Non-pharma Saudi briefs sit on the {link:/bionixus-industries|industries hub}. Japanese teams that also own a China-to-Gulf file should read {link:/market-research/china|Middle East market research for Chinese companies} and the live playbook on {link:/bionixus-industries/insights/chinese-companies-entering-saudi-arabia-and-the-uae|Chinese companies entering Saudi Arabia and the UAE}. The Saudi Press Agency’s public count of more than 750 Chinese companies in the Kingdom ({ext:${SPA_CHINESE_KSA}|SPA, 25 September 2025}) is context for competitive density, not a Japanese TAM.`,
      ],
    },
    {
      id: 'uae-egypt',
      heading: 'UAE and Egypt are separate samples, not a GCC average',
      paragraphs: [
        `UAE market research for a Japanese affiliate has to split Dubai and Abu Dhabi, and it has to say whether the first vehicle is mainland, free zone or a regional HQ that cannot take commercial revenue. MOHAP, DHA and DOH do not share one formulary. A Japanese consumer or automotive brief has the same city split. WAM’s public UAE figures for the Chinese installed base — more than 400,000 residents and over 17,000 companies ({ext:${WAM_CHINESE_UAE}|WAM, 11 June 2026}) — are a reminder that the Gulf is already crowded. They are not a Japanese demand curve.`,
        `Egypt market research is the North Africa chapter Japanese affiliates often add after the Gulf. Cairo leadership in Sheikh Zayed is the BioNixus office that owns that sample. EDA pricing, GAFI licensing and Arabic Egyptian instruments are not a copy of a Gulf guide. See {link:/healthcare-market-research/egypt|healthcare market research in Egypt} and {link:/insights/top-market-research-companies-egypt-2026|top market research companies in Egypt}.`,
        `Comparison pages that Japanese searchers actually use — Intage alternative for Middle East research, or Macromill versus custom MEA research — are on the article backlog for this cluster. Until those spokes are live, this money page states the split: keep Intage or Macromill for Japan; brief BioNixus for MEA primary work. Sibling outbound pages are {link:/market-research/usa|MENA market research company USA} and {link:/market-research/singapore|Middle East market research for Singapore companies}.`,
      ],
    },
    {
      id: 'design-errors',
      heading: 'Design errors we see on Japan-to-MEA briefs',
      paragraphs: [
        `The first error is treating the GCC as one English-speaking cell. Saudi Arabia, the UAE and Egypt do not share a licence, a tender stack or an Arabic dialect that can be copy-pasted. A Japanese affiliate that averages Riyadh, Dubai and Cairo into one “MENA” mean will take an unusable number to Tokyo. Split the sample, or write on page one why the decision is truly regional.`,
        `The second error is a machine-translated Japan discussion guide. Honorifics, disease labels and brand names that work in a Tokyo interview do not survive an Arabic back-translation unless a Gulf moderator has piloted them. BioNixus writes the Arabic instrument for the market and keeps an English master for the Japanese readout. The two files are twins, not a paste.`,
        `The third error is substituting a Japanese-language cell for Arabic. A Japanese cell is correct when the respondent is a Japanese firm, a Japanese hospital visitor, or a Japanese expatriate buyer in Dubai. It is incorrect when the prescriber is a Saudi oncologist or the shopper is an Egyptian household. Write the language plan into the protocol before the first recruit is called.`,
      ],
    },
    {
      id: 'sample-timeline',
      heading: 'Sample, timeline and what Intage or Macromill should keep',
      paragraphs: [
        `A typical Japan-to-MEA healthcare file is a named specialty, country quotas, and a mixed Arabic–English instrument. Oncologists, endocrinologists, cardiologists and hospital pharmacists are the cells Japanese affiliates brief most often. A four-to-eight-week field is normal once the protocol is signed. Payers and NUPCO-facing procurement interviews sit at the long end. A small qualitative cell can be faster; a 300-interview ATU cannot.`,
        `Intage and Macromill should keep the Japan-side tracker, the domestic HCP panel and the Japan consumer work. BioNixus should take the MEA primary sample. The two jobs are complements. A Japanese insights lead who cancels the Japan tracker to fund a Gulf study, or who asks Intage to “add Saudi” as a line on a Japan questionnaire, will get a file that satisfies neither committee.`,
        `Custom work is ${FACTS.priceLow}–${FACTS.priceHigh}. The 48-hour proposal clock starts when the decision, countries, respondents, language and committee date are named. JETRO reports remain useful desk context ({ext:${JETRO_MEA_REPORTS}|JETRO Middle East reports}). They do not replace a named physician or buyer sample. BioNixus does not resell JETRO and does not claim a Tokyo office.`,
      ],
    },
    {
      id: 'how-we-work',
      heading: 'How a Japanese affiliate briefs BioNixus',
      paragraphs: [
        `Tokyo or Osaka writes the commercial question in Japanese or English. Sheridan or London turns it into a protocol. Al Khobar, Dubai and Kuwait recruit. Cairo joins for Egypt. The first deliverable is a written proposal within 48 hours of a usable brief. The second is a fieldwork plan that names countries, quotas, language and the quality gates. The third is a readout a Japanese investment committee can interrogate in English. A Japanese-language page is already live at {link:/ja/market-research/japan|／ja／market-research／japan} and is flagged for native review.`,
        `A Japanese-language cell inside a Gulf study is appropriate when the respondent is a Japanese firm, a Japanese hospital visitor, or a Japanese expatriate buyer. It is not a substitute for Arabic when the prescriber, the tender committee or the consumer is Saudi, Emirati or Egyptian. That is the most common design error we see on Japan-to-MEA briefs.`,
        `Custom work is ${FACTS.priceLow}–${FACTS.priceHigh}. The written guarantees are: ${GUARANTEES}. The slogan is “${FACTS.slogan}” BioNixus never claims guaranteed accuracy. To brief Middle East market research for Japanese companies, use the {link:/contact|contact form} or email {ext:mailto:admin@bionixus.com|admin@bionixus.com}. United States {ext:tel:+18884655557|+1-888-465-5557}. United Kingdom {ext:tel:+447727666682|+44 7727 666682}. Al Khobar {ext:tel:+966501825336|+966 50 182 5336}.`,
        `Japanese teams that also own a US cost centre should read {link:/market-research/usa|MENA market research company USA}. APAC HQs booking from Singapore should read {link:/market-research/singapore|Middle East market research for Singapore companies}. Healthcare country hubs that sit under the same brief are {link:/healthcare-market-research/saudi-arabia|Saudi Arabia}, {link:/healthcare-market-research/uae|the UAE} and {link:/healthcare-market-research/egypt|Egypt}. None of those pages invent a Tokyo office.`,
        `When the Japan affiliate is comparing domestic HCP survey vendors, keep the Japan panel for Japan physicians. An HCP survey that stays inside Japan is a different job from a GCC physician survey. The two questionnaires should not share one sample frame. If a Tokyo steering committee asks for a single “global” mean that mixes Japan and Saudi cells, write the refusal into the proposal. A usable file is a set of country cuts, not an average that hides the Gulf. Japanese consumer, automotive and industrial briefs follow the same split: Japan-side work stays with the Japan supplier; MEA primary work comes here. A Tokyo committee that wants one global mean across Japan and Saudi cells will get that refusal in writing.`,
      ],
    },
  ],
  faqs: [
    {
      question: 'Do you have an office in Japan?',
      answer:
        'No. BioNixus does not claim an office in Japan. Headquarters are in Sheridan, Wyoming. Leadership offices are the USA, the United Kingdom (London) and Cairo (Sheikh Zayed). Field offices are Al Khobar, Dubai and Kuwait. Japanese affiliates brief those offices for Middle East and Africa fieldwork.',
    },
    {
      question: 'What is Middle East market research for Japanese companies?',
      answer:
        'It is commissioned primary research in Saudi Arabia, the UAE, Egypt and the wider GCC for a Japanese affiliate or corporate, covering physicians, payers, buyers or consumers. It is not a Japan domestic study and it is not a JETRO desk report. JETRO remains useful context. BioNixus fields the interviews.',
    },
    {
      question: 'Can you support Saudi market entry from Japan?',
      answer:
        'Yes. The brief has to name the Saudi buyer, city, licence path and channel before Tokyo remits capital. A Dubai free-zone company does not replace a MISA activity or an SFDA file. Custom work is $10,000–$60,000. Scope is guaranteed in writing.',
    },
    {
      question: 'Should we keep Intage or Macromill?',
      answer:
        'Keep them for Japan-side work. Brief BioNixus when the sample is in the Middle East or Africa. The two jobs are complements. A comparison spoke on Intage alternatives for Middle East research is on the 2026 article backlog.',
    },
    {
      question: 'Do you run UAE and Egypt studies for Japanese affiliates?',
      answer:
        'Yes. UAE work splits Dubai and Abu Dhabi and respects MOHAP, DHA and DOH. Egypt work is run with the Cairo leadership office. Do not average the two countries into one “MENA” cell unless the decision is truly regional.',
    },
    {
      question: 'Is there a Japanese-language page?',
      answer:
        'Yes. The Japanese twin is /ja/market-research/japan. It is written for native reading and flagged for native review. Hreflang pairs the two URLs.',
    },
    {
      question: 'Do you guarantee the accuracy of the findings?',
      answer:
        'No. BioNixus never claims guaranteed accuracy. The written guarantees are replacement of non-qualifying respondents, a minimum sample, re-field at our cost, and a pilot fee credited to the main field.',
    },
  ],
  relatedLinks: [
    { to: PATHS.japanJa, label: '日本企業向け中東市場調査' },
    { to: PATHS.usa, label: 'MENA market research company USA' },
    { to: PATHS.china, label: 'Middle East market research for Chinese companies' },
    { to: PATHS.singapore, label: 'Middle East market research for Singapore companies' },
    { to: '/healthcare-market-research', label: 'Healthcare market research hub' },
    { to: '/healthcare-market-research/japan', label: 'Healthcare market research in Japan' },
    { to: '/bionixus-industries', label: 'Industries hub' },
  ],
  hreflang: INTL_HREFLANG_BY_PATH[PATHS.japan],
};
